Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data

20250 citationsJournal Articlegold Open Access

Authors

Matthew F. Wipperman · Regeneron (United States)

Peter J. Ehmann · Regeneron (United States)

Debra A.G. McIntyre · Regeneron (United States)

Chenguang Wang · Regeneron (United States)

Haitao Gao · Regeneron (United States)

Poulabi Banerjee · Regeneron (United States)

Kei Ogawa ·

Abstract

Change in ALP (baseline to week 16) was associated with AA events after treatment with fasinumab. Other measured peripheral biomarkers were not linked with AA events.

Topics & Keywords

Alkaline Phosphatase Research Studies Inflammatory Myopathies and Dermatomyositis Spondyloarthritis Studies and Treatments

Publication Details

Published in: Osteoarthritis and Cartilage Open

Volume 8, Issue 1, pp. 100735-100735

DOI: 10.1016/j.ocarto.2025.100735

Field-Weighted Citation Impact: 0.00

Command Palette

Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data

Authors

Abstract

Topics & Keywords

Publication Details